A totally synthetic polyoxime malaria vaccine containing Plasmodium falciparum B cell and universal T cell epitopes elicits immune responses in volunteers of diverse HLA types

Journal of Immunology

Volumn 166, Issue 1, 2001, Pages 481-489

  Nardin, E H ^a   Calvo Calle, J M ^a   Oliveira, G A ^a   Nussenzweig, R S ^a   Schneider, M ^a   Tiercy, J M ^a   Loutan, L ^a   Hochstrasser, D ^a   Rose, K ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA ANTIGEN; MALARIA VACCINE; POLYOXIME; UNCLASSIFIED DRUG;

ADULT; ARTICLE; B LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL TRIAL; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; MALE; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SPOROZOITE; T LYMPHOCYTE;

EID: 0035168781     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.1.481     Document Type: Article

References (38)

1. Rationale for the development of an engineered sporozoite malaria vaccine
2. Safety and immungenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites
3. Synthetic peptide vaccine design: Synthesis and properties of a high density multiple antigenic peptide system
4. Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria
5. Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine
6. Protective immunity induced in squirrel monkeys with a multiple antigen construct against the circumsporozoite protein of Plasmodium vivax
7. A synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes
8. + clones from a malaria-immunized volunteer
9. Successful immunization of humans with irradiated malaria sporozoites: Humoral and cellular responses of the protected individuals
10. + T cells from a sporozoite-irnmunized volunteer recognize the P. falciparum CS protein
11. + T cell clones obtained from Plasmodium falciparum sporozoite immunized volunteers recognize polymorphic sequences of the circumsporozoite protein
12. Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: Identification of a universal T cell epitope in the Plasmodium falciparum CS protein
13. Facile synthesis of homogeneous artificial proteins
14. A synthetic analogue of Escherichia coli lipoprotein, tripalmitoyl pentapeptide constitutes a potent immune adjuvant
15. Synthesis of a new template with a built-in adjuvant and its use in constructing peptide vaccine candidates through polyoxime chemistry
16. Plasmodium falciparum polyoximes: Highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T-cell epitope of CS protein
17. Totally synthetic lipid-containing polyoxime peptide constructs are potent immunogens
18. Oligonucleotide genotyping of HLA polymorphism on microtitre plates
19. Oligotyping for HLA-A2, -A3, and -B44-subtypes: Detection of subtype incompatibilities between patients and their serologically matched unrelated bone marrow donors
20. Protective immunity produced by the injection of X-irradiated sporozoites of Plasmodium berghei V. In vitro effects of immune serum on sporozoites
21. Immunity to falciparum and vivax malaria induced by irradiated sporozoites: A review of the University of Maryland studies, 1971-75
22. + T cells using an ELISPOT assay
23. Localization of HLA-A2.1-restricted T cell epitopes in the circumsporozoite protein of Plasmodium falciparum
24. The minimum peptide epitope from the influenza virus matrix protein: Extra- and intracellular loading of HLA-A2
25. Inhibition of development of exo-erythrocytic forms of malaria parasites by γ interferon
26. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees
27. The Hepatitis B virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection
28. Plasmodium berghei sporozoite invasion is blocked in vitro by sporozoite-immobilizing antibodies
29. TRAP is necessary for gliding motility and infectivity of plasmodium sporozoites
30. The basolateral domain of the hepatocyte plasma membrane bears receptors for the circumsporozoite protein of Plasmodium falciparum sporozoites
31. Dominance and crypticity of T cell antigenic determinants
32. Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices
33. Lack of response to recombinant hepatitis B vaccine in nonresponders to the plasma vaccine
34. Immunogenetic mechanisms of antibody response to measles vaccine: The role of HLA genes
35. T cell responses to pre-erythrocytic stages of malaria: Role in protection and vaccine development
36. + T cell- and IFN-γ-dependent elimination of infected hepatocytes
37. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria
38. Potent induction of focused Th1-type cellular and humoral immune responses by RTS, S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine